Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Pericytes in Bone Marrow.

Kunisaki Y.

Adv Exp Med Biol. 2019;1122:101-114. doi: 10.1007/978-3-030-11093-2_6. Review.

PMID:
30937865
2.

Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis.

Kidoya H, Muramatsu F, Shimamura T, Jia W, Satoh T, Hayashi Y, Naito H, Kunisaki Y, Arai F, Seki M, Suzuki Y, Osawa T, Akira S, Takakura N.

Nat Commun. 2019 Mar 6;10(1):1072. doi: 10.1038/s41467-019-09028-w.

3.

Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth.

Oshima T, Niwa Y, Kuwata K, Srivastava A, Hyoda T, Tsuchiya Y, Kumagai M, Tsuyuguchi M, Tamaru T, Sugiyama A, Ono N, Zolboot N, Aikawa Y, Oishi S, Nonami A, Arai F, Hagihara S, Yamaguchi J, Tama F, Kunisaki Y, Yagita K, Ikeda M, Kinoshita T, Kay SA, Itami K, Hirota T.

Sci Adv. 2019 Jan 23;5(1):eaau9060. doi: 10.1126/sciadv.aau9060. eCollection 2019 Jan.

4.

Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.

Nakano M, Kikushige Y, Miyawaki K, Kunisaki Y, Mizuno S, Takenaka K, Tamura S, Okumura Y, Ito M, Ariyama H, Kusaba H, Nakamura M, Maeda T, Baba E, Akashi K.

Oncogene. 2019 Feb;38(6):780-793. doi: 10.1038/s41388-018-0480-0. Epub 2018 Sep 4.

PMID:
30181548
5.

Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2302-2309. doi: 10.1016/j.bbmt.2018.06.002. Epub 2018 Jun 15.

PMID:
29909153
6.

Identification of unipotent megakaryocyte progenitors in human hematopoiesis.

Miyawaki K, Iwasaki H, Jiromaru T, Kusumoto H, Yurino A, Sugio T, Uehara Y, Odawara J, Daitoku S, Kunisaki Y, Mori Y, Arinobu Y, Tsuzuki H, Kikushige Y, Iino T, Kato K, Takenaka K, Miyamoto T, Maeda T, Akashi K.

Blood. 2017 Jun 22;129(25):3332-3343. doi: 10.1182/blood-2016-09-741611. Epub 2017 Mar 23.

7.

Differential cytokine contributions of perivascular haematopoietic stem cell niches.

Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez NF, Birbrair A, Ma'ayan A, Frenette PS.

Nat Cell Biol. 2017 Mar;19(3):214-223. doi: 10.1038/ncb3475. Epub 2017 Feb 20.

8.

Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations.

Yurino A, Takenaka K, Yamauchi T, Nunomura T, Uehara Y, Jinnouchi F, Miyawaki K, Kikushige Y, Kato K, Miyamoto T, Iwasaki H, Kunisaki Y, Akashi K.

Stem Cell Reports. 2016 Sep 13;7(3):425-438. doi: 10.1016/j.stemcr.2016.07.002. Epub 2016 Aug 4.

9.

Fetal liver hematopoietic stem cell niches associate with portal vessels.

Khan JA, Mendelson A, Kunisaki Y, Birbrair A, Kou Y, Arnal-Estapé A, Pinho S, Ciero P, Nakahara F, Ma'ayan A, Bergman A, Merad M, Frenette PS.

Science. 2016 Jan 8;351(6269):176-80. doi: 10.1126/science.aad0084. Epub 2015 Dec 3.

10.

[The hematopoietic stem cell niche].

Kunisaki Y.

Rinsho Ketsueki. 2015 Oct;56(10):1888-93. doi: 10.11406/rinketsu.56.1888. Japanese.

PMID:
26458426
11.

Neutrophil ageing is regulated by the microbiome.

Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, Burk RD, Kunisaki Y, Jang JE, Scheiermann C, Merad M, Frenette PS.

Nature. 2015 Sep 24;525(7570):528-32. doi: 10.1038/nature15367. Epub 2015 Sep 16.

12.

[Distinct vascular niches determine hematopoietic stem cell fate].

Kunisaki Y.

Rinsho Ketsueki. 2015 Jun;56(6):606-13. doi: 10.11406/rinketsu.56.606. Japanese.

PMID:
26256869
13.

[Cancer stem cells and the niches].

Kunisaki Y.

Nihon Rinsho. 2015 May;73(5):739-44. Review. Japanese.

PMID:
25985624
14.

Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion.

Bruns I, Lucas D, Pinho S, Ahmed J, Lambert MP, Kunisaki Y, Scheiermann C, Schiff L, Poncz M, Bergman A, Frenette PS.

Nat Med. 2014 Nov;20(11):1315-20. doi: 10.1038/nm.3707. Epub 2014 Oct 19.

15.

Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.

Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y, Lacombe J, Armstrong SA, Dührsen U, Frenette PS.

Cell Stem Cell. 2014 Sep 4;15(3):365-375. doi: 10.1016/j.stem.2014.06.020. Epub 2014 Jul 10.

16.

Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development.

Mizoguchi T, Pinho S, Ahmed J, Kunisaki Y, Hanoun M, Mendelson A, Ono N, Kronenberg HM, Frenette PS.

Dev Cell. 2014 May 12;29(3):340-9. doi: 10.1016/j.devcel.2014.03.013.

17.

Influences of vascular niches on hematopoietic stem cell fate.

Kunisaki Y, Frenette PS.

Int J Hematol. 2014 Jun;99(6):699-705. doi: 10.1007/s12185-014-1580-4. Epub 2014 Apr 23. Review.

PMID:
24756874
18.

Arteriolar niches maintain haematopoietic stem cell quiescence.

Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS.

Nature. 2013 Oct 31;502(7473):637-43. doi: 10.1038/nature12612. Epub 2013 Oct 9.

19.

PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion.

Pinho S, Lacombe J, Hanoun M, Mizoguchi T, Bruns I, Kunisaki Y, Frenette PS.

J Exp Med. 2013 Jul 1;210(7):1351-67. doi: 10.1084/jem.20122252. Epub 2013 Jun 17.

20.

Rhythmic modulation of the hematopoietic niche through neutrophil clearance.

Casanova-Acebes M, Pitaval C, Weiss LA, Nombela-Arrieta C, Chèvre R, A-González N, Kunisaki Y, Zhang D, van Rooijen N, Silberstein LE, Weber C, Nagasawa T, Frenette PS, Castrillo A, Hidalgo A.

Cell. 2013 May 23;153(5):1025-35. doi: 10.1016/j.cell.2013.04.040.

21.

Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration.

Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS.

Nat Med. 2013 Jun;19(6):695-703. doi: 10.1038/nm.3155. Epub 2013 May 5.

22.

CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stress.

Chow A, Huggins M, Ahmed J, Hashimoto D, Lucas D, Kunisaki Y, Pinho S, Leboeuf M, Noizat C, van Rooijen N, Tanaka M, Zhao ZJ, Bergman A, Merad M, Frenette PS.

Nat Med. 2013 Apr;19(4):429-36. doi: 10.1038/nm.3057. Epub 2013 Mar 17.

23.

Circadian control of the immune system.

Scheiermann C, Kunisaki Y, Frenette PS.

Nat Rev Immunol. 2013 Mar;13(3):190-8. doi: 10.1038/nri3386. Epub 2013 Feb 8. Review.

24.

Adrenergic nerves govern circadian leukocyte recruitment to tissues.

Scheiermann C, Kunisaki Y, Lucas D, Chow A, Jang JE, Zhang D, Hashimoto D, Merad M, Frenette PS.

Immunity. 2012 Aug 24;37(2):290-301. doi: 10.1016/j.immuni.2012.05.021. Epub 2012 Aug 2.

25.

The secrets of the bone marrow niche: Enigmatic niche brings challenge for HSC expansion.

Kunisaki Y, Frenette PS.

Nat Med. 2012 Jun 6;18(6):864-5. doi: 10.1038/nm.2825. No abstract available.

26.

Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields.

Lucas D, Bruns I, Battista M, Mendez-Ferrer S, Magnon C, Kunisaki Y, Frenette PS.

Blood. 2012 Apr 26;119(17):3962-5. doi: 10.1182/blood-2011-07-367102. Epub 2012 Mar 14.

27.

Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, Ginhoux F, Ochando JC, Kunisaki Y, van Rooijen N, Liu C, Teshima T, Heeger PS, Stanley ER, Frenette PS, Merad M.

J Exp Med. 2011 May 9;208(5):1069-82. doi: 10.1084/jem.20101709. Epub 2011 May 2.

28.

Neutrophil microdomains: linking heterocellular interactions with vascular injury.

Scheiermann C, Kunisaki Y, Jang JE, Frenette PS.

Curr Opin Hematol. 2010 Jan;17(1):25-30. doi: 10.1097/MOH.0b013e328333d2a3. Review.

29.

Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.

Nonami A, Miyamoto T, Kuroiwa M, Kunisaki Y, Kamezaki K, Takenaka K, Harada N, Teshima T, Harada M, Nagafuji K.

Jpn J Clin Oncol. 2007 Dec;37(12):969-72. Epub 2007 Nov 30.

PMID:
18055567
30.

T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2.

Tanaka Y, Hamano S, Gotoh K, Murata Y, Kunisaki Y, Nishikimi A, Takii R, Kawaguchi M, Inayoshi A, Masuko S, Himeno K, Sasazuki T, Fukui Y.

Nat Immunol. 2007 Oct;8(10):1067-75. Epub 2007 Sep 2.

PMID:
17767160
31.

Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group.

Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y, Kamezaki K, Tu L, Hisaeda H, Takenaka K, Harada N, Kamimura T, Ohno Y, Eto T, Teshima T, Gondo H, Harada M, Nagafuji K.

Eur J Haematol. 2007 Oct;79(4):317-21. Epub 2007 Aug 3.

PMID:
17680814
32.

Marked improvement of cardiac function early after non-myeloablative BMT in a heavily transfused patient with severe aplastic anemia and heart failure.

Kunisaki Y, Takase K, Miyamoto T, Fukata M, Nonami A, Kamezaki K, Kaji Y, Gondo H, Harada M, Nagafuji K.

Bone Marrow Transplant. 2007 Sep;40(6):593-5. Epub 2007 Jul 9. No abstract available.

PMID:
17618320
33.

DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis.

Kunisaki Y, Nishikimi A, Tanaka Y, Takii R, Noda M, Inayoshi A, Watanabe K, Sanematsu F, Sasazuki T, Sasaki T, Fukui Y.

J Cell Biol. 2006 Aug 28;174(5):647-52.

34.

DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.

Kunisaki Y, Tanaka Y, Sanui T, Inayoshi A, Noda M, Nakayama T, Harada M, Taniguchi M, Sasazuki T, Fukui Y.

J Immunol. 2006 Apr 15;176(8):4640-5.

35.

Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.

Jiang H, Pan F, Erickson LM, Jang MS, Sanui T, Kunisaki Y, Sasazuki T, Kobayashi M, Fukui Y.

J Exp Med. 2005 Oct 17;202(8):1121-30.

36.

[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].

Koyama M, Matsuoka K, Kunisaki Y, Takeuchi M, Matsue K.

Rinsho Ketsueki. 2004 Oct;45(10):1115-8. Japanese.

PMID:
15553047
37.

Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.

Nombela-Arrieta C, Lacalle RA, Montoya MC, Kunisaki Y, Megías D, Marqués M, Carrera AC, Mañes S, Fukui Y, Martínez-A C, Stein JV.

Immunity. 2004 Sep;21(3):429-41.

38.

Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor.

Kunisaki Y, Masuko S, Noda M, Inayoshi A, Sanui T, Harada M, Sasazuki T, Fukui Y.

Blood. 2004 May 1;103(9):3362-4. Epub 2004 Jan 8.

40.

Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6.

Kunisaki Y, Goto H, Kitagawa K, Nagano M.

Intern Med. 2003 Feb;42(2):203-7.

41.

[Intranasal administration of nitroglycerin solution and nitroglycerin spray during general anesthesia].

Iwasaka H, Kunisaki Y, Yamamoto H, Kitano T, Kinoshita R, Taniguchi K, Honda N.

Masui. 1993 Oct;42(10):1423-8. Japanese.

PMID:
8230691
42.

Supplemental Content

Loading ...
Support Center